News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Death Forces FDA to Place Clinical Hold on Advaxis (ADXS) Cancer Drug     10/7/2015
Express Scripts to Cover Amgen (AMGN), Regeneron (REGN)'s Pricey New Cholesterol Drugs     10/7/2015
Clal Biotech (CLALF) Opts Out of Re-Acquiring Andromeda from Hyperion (HPTX) After Phase III Diabetes Drug Tanks     10/7/2015
Genocea Biosciences (GNCA)'s GEN-003 Meets Primary Endpoint In Phase II Genital Herpes Trial     10/7/2015
30-Year-Old Hedge-Fund Whiz Kid’s Axovant (AXON) Starts Alzheimer’s Phase III Trial     10/6/2015
Exelixis (EXEL), Genentech (RHHBY)'s Cobimetinib Succeeds in Pivotal Phase III Trial     10/6/2015
FDA Green Lights Alkermes (ALKS)' Schizophrenia Treatment Aristada     10/6/2015
Bristol-Myers Squibb (BMY) Snags FDA's Priority Review for Daklinza SNDAs     10/6/2015
Spark Therapeutics (ONCE) Soars as Eye Drug Hits Goals in Pivotal Phase III Study     10/5/2015
Gilead (GILD) Scores FDA Approval of Letairis Combo as PAH Treatment     10/5/2015
Stratatech Awarded $247 Million BARDA Project     10/5/2015
Clovis Oncology (CLVS) and AstraZeneca PLC (AZN) Duke it Out Over Lung and Ovarian Cancer Drugs     10/5/2015
Regeneron (REGN) Forges $325 Million Pain Pact with Mitsubishi Tanabe     10/5/2015
Visterra, Inc. Awarded Contract Valued at Up to $204.5 Million     10/5/2015
Top 10 Best-Selling Biotech Drugs     10/2/2015

News from Around the Web
World's Oldest Woman Says She Eats Bacon Daily     10/7/2015
It's Time To Get Your Flu Shot     10/7/2015
Sex Dramatically Increase Chances Of Pregnancy, Indiana University Study     10/7/2015
Weight Loss, Exercise May Boost Fertility Odds For Women With PCOS, Pennsylvania State College Of Medicine     10/7/2015
Gut Microbes Linked To Anorexia, University of North Carolina Study     10/7/2015
New Test Predicts Teens' Heart Disease Risk, University Of Virginia Children's Hospital     10/7/2015
Trapping Cells That Tumors Release Allows Fast And Sensitive Genetic Analysis, A*STAR Study     10/7/2015
Researcher Optimistic Alzheimer's Can Be Delayed By Five Years     10/7/2015
Women With Alzheimer’s-Related Gene Lose Weight More Sharply After Age 70, SUNY Downstate Medical Center Study     10/6/2015
Cancer Drug Appears To Sharpen Memory Too, Rutgers, The State University Of New Jersey Study     10/6/2015
Self-Propelled Powder To Stop Bleeding Created, University of British Columbia Researchers     10/6/2015
New On-Chip Optical Sensing Technique Used To Detect Multiple Flu Strains, University of California, Santa Cruz (UCSC) and Brigham Young University Study     10/6/2015
Computer System Being Developed to Predict Change In The Alzheimer's Brain, MIT Study     10/6/2015
Picture This: An App For Blind Photographers, University of California, Santa Cruz (UCSC) Study     10/6/2015
Late Bedtimes Linked To Weight Gain, University of California, Berkeley (CAL) Study     10/5/2015

Press Releases
Dermira Presents Data From DRM01 Phase IIa Trial At European Academy Of Dermatology And Venereology     10/7/2015
LONSURF (Trifluridine And Tipiracil) Approved For Refractory Metastatic Colorectal Cancer, Available At Biologics, Inc. (NC)     10/7/2015
Immune Pharmaceuticals, Inc. Submits Investigational New Drug Application (IND) In The U.S. For Its Lead Product Candidate Bertilimumab For The Treatment Of Bullous Pemphigoid     10/7/2015
Nektar Therapeutics (NKTR) Submits Investigational New Drug Application (IND) for NKTR-214 To Treat Solid Tumor Malignancies     10/7/2015
BrainStorm Cell Therapeutics Inc. Announces Treatment Of Final Patient In US Multicenter Double Blinded Phase 2 ALS Trial     10/7/2015
Sebacia Announces Completion Of Enrollment In Pivotal U.S. Clinical Trial For Severe Acne     10/7/2015
Ascend Announces Patients With Nodular Basal Cell Carcinoma Receives First Dose Of ASN-002 In Phase 1/2a Study     10/7/2015
CollPlant Announces Completion Of Patient Recruitment For Clinical Trial Of VergenixFG (Flowable Gel) For The Treatment Of Chronic Wounds     10/7/2015
Seattle Genetics (SGEN) Announces Initiation Of Phase I/II Clinical Trial Of ADCETRIS (Brentuximab Vedotin) In Combination With Opdivo (Nivolumab) In Second-Line Hodgkin Lymphoma     10/7/2015
Kadimastem Submitted Pre-IND Package To The FDA     10/7/2015
Marathon Pharmaceuticals, LLC Receives Rare Pediatric Disease Designation From FDA For Deflazacort As A Potential Treatment Of Duchenne Muscular Dystrophy     10/7/2015
C4X Discovery Release: Research Update: Small Molecule Leads Against IL-17 For Inflammation And Autoimmune Diseases     10/7/2015
Lion Biotechnologies, Inc. Obtains Exclusive License From NIH To Develop And Commercialize TIL In Bladder, Lung, Breast And HPV-Associated Cancers     10/7/2015
OBI Pharmaceuticals (SHPG) Signs Exclusive Agreement With Merck & Co. (MRK) For Antibiotic Drug     10/7/2015
NIH Awards City of Hope $2.2 Million Grant For Study Of Diabetes, Epigenetics     10/7/2015